NESS ZIONA, Israel, Feb. 8,
2022 /PRNewswire/ -- MeaTech 3D Ltd., (NASDAQ-CM:
MITC), an international food technology company at the forefront of
the cultured meat industry, today revealed significant
improvement in its differentiation process from stem cells to
muscle fibers. The company has succeeded in accelerating the
formation of real living muscle fibers and enhancing their quality
to mirror key characteristics of farm-raised meat.
These results show the process in which bovine stem cells were
isolated, proliferated in the lab, and differentiated into matured
muscle cells with improved muscle fiber density, thickness and
length. Based on these improvements, MeaTech has filed a
provisional patent application with the USPTO.
Arik Kaufman, CEO of
MeaTech: "Today's achievement is another important step
towards our goal of developing a true replacement for conventional
meat. We are committed to advancing our cellular technology to
attain a cultivated-meat-eating experience that replicates that of
farm-raised meat. This achievement follows our recent announcement
that we successfully 3D printed an almost 4 oz steak comprised of
actual living muscle and fat tissue."
Yaron Kaiser, Chairman of the
Board, MeaTech: "MeaTech's wonderful results, led by our
technology team, place the company at the forefront of the cultured
meat revolution.
The professionalism and capabilities of a small, elite, and
goal-oriented technological team are enabling MeaTech to achieve
significant and groundbreaking achievements efficiently and
quickly, giving the company a clear competitive advantage in an
industry that is on a secure path to changing our lives and the way
we consume meat. "
About MeaTech 3D
MeaTech is an international food technology company at the
forefront of the cultured meat revolution. The company is listed on
the Nasdaq Capital Market under the ticker "MITC".
MeaTech initiated activities in 2019 and maintains
facilities in Ness Ziona, Israel
and Antwerp, Belgium. The company
believes cultivated meat technologies hold significant potential to
improve meat production, simplify the meat supply chain, and offer
consumers a range of new product offerings.
MeaTech aims to provide an alternative to industrialized animal
farming, circumventing the serious issues surrounding conventional
animal husbandry, such as carbon footprint, water resources and
animal welfare. By adopting a modular factory design, MeaTech will
be able to offer a sustainable solution for a variety of species,
including beef, chicken, and pork, both as raw materials and whole
cuts; and also provide the production equipment.
For more information, please visit
https://meatech3d.com
Forward-Looking Statements
This press release contains forward-looking statements
concerning MeaTech's business, operations and financial performance
and condition as well as plans, objectives, and expectations for
MeaTech's business operations and financial performance and
condition. Any statements that are not historical facts may be
deemed to be forward-looking statements. Forward-looking statements
reflect MeaTech's current views with respect to future events and
are based on assumptions and subject to known and unknown risks and
uncertainties, which change over time, and other factors that may
cause MeaTech's actual results, performance or achievements to be
materially different from any future results, performance or
achievements expressed or implied by the forward-looking
statements. Forward-looking statements include, without limitation,
any statement that may predict, forecast, indicate or imply future
results, performance or achievements, and are typically identified
with words such as "may," "could," "should," "will," "would,"
"believe," "anticipate," "estimate," "expect," "aim," "intend,"
"plan" or words or phases of similar meaning and include, without
limitation, MeaTech's expectations regarding the success of its
cultured meat manufacturing technologies it is developing, which
will require significant additional work before MeaTech can
potentially launch commercial sales; MeaTech's research and
development activities associated with technologies for cultured
meat manufacturing, including three-dimensional meat production,
which involves a lengthy and complex process; MeaTech's ability to
obtain and enforce its intellectual property rights and to operate
its business without infringing, misappropriating, or otherwise
violating the intellectual property rights and proprietary
technology of third parties; and other risks and uncertainties,
including those identified in MeaTech's Annual Report on Form 20-F
for the fiscal year ended December 31,
2020, filed with the Securities and Exchange Commission on
April 21, 2021. New risks and
uncertainties may emerge from time to time, and it is not possible
for MeaTech to predict their occurrence or how they will affect
MeaTech. If one or more of the factors affecting MeaTech's
forward-looking information and statements proves incorrect, then
MeaTech's actual results, performance or achievements could differ
materially from those expressed in, or implied by, forward-looking
information and statements contained in this press release.
Therefore, MeaTech cautions you not to place undue reliance on its
forward-looking information and statements. MeaTech disclaims any
duty to revise or update the forward-looking statements, whether
written or oral, to reflect actual results or changes in the
factors affecting the forward-looking statements, except as
specifically required by law.
MeaTech Press
Contact:
|
MeaTech Investor
Contacts:
|
|
Alan Ryan
Rainier Communications
alanryan@rainierco.com
|
Joseph Green
Edison Group
jgreen@edisongroup.com
|
Ehud Helft
Edison Israel
ehelft@edisongroup.com
|
|
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/meatech-reveals-promising-results-with-muscle-stem-cell-differentiation-301477505.html
SOURCE MeaTech 3D Ltd.